ChemoGuard Diagnostics, a screening test that may help doctors tailor chemotherapy to individual patients.
Chemoguard provides personalized toxicity screening for chemotherapy patients.
Chemotherapy treatments are approved through large-scale clinical trials with an average acceptable toxicity response for a trial population. The problem with this approach is that you, as a person, don’t have an average toxicity response. A major challenge for doctors is prescribing the right drug at the ideal dose to eliminate cancer without toxicity.
Chemoguard provides a service that, from one small sample of skin, assesses your own sensitivity to the chemotherapy drugs that your doctor is considering. Thanks to recent developments in stem cell technology, we now have the capability to screen multiple drugs on your own heart, nerve, and bone marrow cells in a time and cost effective way. In 6 weeks, Chemoguard’s toxicity score will complement your doctor’s intuition by revealing your unique sensitivities, allowing for the best possible treatment.
“Most medical treatments have been designed for the average patient — treatments can be very successful for some patients but not for others.”
By preventing the use of ineffective treatments and improving survival rates, it takes the guesswork out of personalized care.